If I tell you, I will have to kill you. Just kidding.
I don't mean to be vague, but it is my understanding
that negotiations for SterOx continue positively, and
are probably in the 90% to 95% completion range. However,
the last 5% is usually the toughest and can take time. It
is my wish that Cyclopss would keep SterOx. I believe the
product could have sales in the $200 million plus range
within 3 years of FDA approval, and with the kind of profit
margins a non-corrosive, liquid, cold, non-toxic high livel
gemacide or sterilent would have, gross margins of at least
$80 million could be achieved. Do the math, Cyclopss could
earn as much as $4 per share based on current capitalization.
I would urge you to ask some people in the medical field to
verify the kind of market for a product like SterOx. Hospitals,
dentist offices, doctor offices, veternarians, nursing homes,
food processors, etc, etc,.There is a company named Steris
which in 1992 developed a liquid sterilent, corrosive though,
called peracetic acid - check out what happened to that company's
success. SterOx has a much larger market than peracetic acid.
Regarding the Columbia/HCA test, late June for results. These
tests will verify and validate Cyclopss own tests. The timing
of Mr. Jim Gross, president of the textile division, coming on
board is interesting. He has the experience and know how to
put in place systems for large institutions which Columbia
definitely is. It is also interesting that Cinergy will be
monitoring the tests also to validate the energy savings.
Though Columbia would be the ultimate prize and would open
the entire healthcare market for Cyclopss, there are many other
large institutional laundries who are looking close at ozonated
laudry systems, and I do expect sales shortly.
Regarding price, who knows, your guess is as good as mine. My
own goal is $3 to $5 by Labor Day. If they kept SterOx, the
long term price target could be quite high. If their Ster-O-
Zone system, ozone gas sterilizer, comes on stream, really high.
Of course, this is all just speculation,but for a $1 stock, it
does have some interesting upside potential.
GBuckley |
